Results 171 to 180 of about 319,380 (216)
New Aspects in Joint and Bone Processes in Psoriatic Arthritis (PSA)
openaire +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
HLA-C locus alleles in patients with psoriatic arthritis (PsA)
Human Immunology, 1999The aim of this investigation was to compare the frequency of alleles at the HLA-C locus in patients with psoriatic arthritis to that in the disease free population and to relate the HLA genes to disease phenotype in psoriatic arthritis (PsA). Ninety-four consecutive patients seen in the (PsA) clinic between April and July 1996 and 100 disease-free ...
Dafna D. Gladman
exaly +3 more sources
INTRODUCTION: Low disease activity (LDA)/remission is the target of treatment in patients with psoriatic arthritis (PsA). We assessed the proportions of patients with PsA receiving upadacitinib who achieved LDA/remission over 1 year.
Arthur Kavanaugh +2 more
exaly +2 more sources
AB0754 Psoriatic Arthritis (PSA): an Indian Perspective
Annals of the Rheumatic Diseases, 2014Background Psoriatic arthritis is a major rheumatological problem. The heterogenous phenotype spectrum spans from RA like to a typical AS. There are few descriptions from India Objectives To evaluate the clinical phenotype & immunology pattern of a patients with psoriatic arthritis. Methods We conducted a retrospective study to define the clinical
N.D. Nahar +4 more
openaire +1 more source
Psoriatic Arthritis (PSA) - An Analysis of 220 Patients
QJM: An International Journal of Medicine, 1987Abstract Since 1978, 220 patients with psoriatic arthritis have undergone detailed study at the Women's College Hospital in Toronto, Canada. Clinical, radiological and biochemical data were subjected to computer analysis in order to determine clinical-biochemical correlations within subsets of patients with psoriatic arthritis.
D D, Gladman +4 more
openaire +2 more sources
Annals of the Rheumatic Diseases, 2020
Background: Clinical patterns and disease burden of PsA varies in different parts of the world. Demographic studies from Indian subcontinent are sparse Objectives: To study the cutaneous, articular profile of PsA and describe their disease activity, disability and co-morbidities (CMs) Methods: This is a multicenter, cross-sectional, non ...
C. Kodishala +23 more
openaire +1 more source
Background: Clinical patterns and disease burden of PsA varies in different parts of the world. Demographic studies from Indian subcontinent are sparse Objectives: To study the cutaneous, articular profile of PsA and describe their disease activity, disability and co-morbidities (CMs) Methods: This is a multicenter, cross-sectional, non ...
C. Kodishala +23 more
openaire +1 more source
Psoriatic Arthritis in Canadian Clinical Practice: The PsA Assessment in Rheumatology
The Journal of Rheumatology, 2012Objective.We aimed to determine disease severity and treatment of patients with psoriatic arthritis (PsA) in rheumatology practices in Canada through the PsA Assessment in Rheumatology (PAIR) study.Methods.Rheumatologists who were members of the Canadian Rheumatology Association were asked to complete a form for each patient addressing demographic ...
Dafna D, Gladman +3 more
openaire +2 more sources
Radiographic Assessment of Psoriatic Arthritis (PsA)
2016Radiographs are accessible, inexpensive and safe, and therefore remain the generally accepted means for imaging assessment of joint disease in PsA. Radiographs can help in making a diagnosis of PsA, are useful in differentiating PsA from other diseases, and have been used as an outcome measure in the clinical trials and observational studies in PsA ...
Javier Rosa +2 more
openaire +1 more source
Annals of the Rheumatic Diseases, 2015
Objectives New drugs have become available in PsA. As part of the update of the EULAR recommendations for the management of PsA, we performed a systematic literature review to assess the efficacy and safety of pharmacological agents for the management of patients with PsA.
Ramiro, S. +9 more
openaire +1 more source
Objectives New drugs have become available in PsA. As part of the update of the EULAR recommendations for the management of PsA, we performed a systematic literature review to assess the efficacy and safety of pharmacological agents for the management of patients with PsA.
Ramiro, S. +9 more
openaire +1 more source
The Journal of Rheumatology, 2010
Objective.To develop a recommended measure of response for use in psoriatic arthritis (PsA) clinical trials and observational cohort studies reflecting joint involvement.Methods.Previously, we used data from phase III randomized placebo-controlled trials of anti-tumor necrosis factor (TNF) agents to determine models, based primarily on statistical ...
Dafna D, Gladman +3 more
openaire +2 more sources
Objective.To develop a recommended measure of response for use in psoriatic arthritis (PsA) clinical trials and observational cohort studies reflecting joint involvement.Methods.Previously, we used data from phase III randomized placebo-controlled trials of anti-tumor necrosis factor (TNF) agents to determine models, based primarily on statistical ...
Dafna D, Gladman +3 more
openaire +2 more sources

